Evaluation of maternal serum progesterone-induced blocking factor levels in pregnancies complicated with early- and late-onset preeclampsia

References

• Beta J, Szekeres-Bartho J, Skyfta E, Akolekar R, Nicolaides KH. 2011. Maternal serum progesterone-induced blocking factor at 11–13 weeks’ gestation in spontaneous early preterm delivery. Fetal Diagnosis and Therapy 29:197–200.
   PubMed Web of Science ®Google Scholar
• Cemgil Arikan D, Aral M, Coskun A, Ozer A. 2012. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. The Journal of Maternal-Fetal & Neonatal Medicine 25:1569–1573.
   PubMed Web of Science ®Google Scholar
• Check J, Levin E, Bollendorf A, Locuniak J. 2005. Miscarriage in the first trimester according to the presence or absence of the progesterone-induced blocking factor at three to five weeks from conception in progesterone supplemented women. Clinical and Experimental Obstetrics & Gynecology 32:13–14.
   PubMedGoogle Scholar
• Check JH, Arwitz M, Gross J, Peymer M, Szekeres-Bartho J. 1997a. Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF). American Journal of Reproductive Immunology 37:17–20.
   PubMed Web of Science ®Google Scholar
• Check JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH. 1997b. Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception. American Journal of Reproductive Immunology 38:6–8.
   PubMed Web of Science ®Google Scholar
• Cubro H, Kashyap S, Nath MC, Ackerman AW, Garovic VD. 2018. The role of interleukin-10 in the pathophysiology of preeclampsia. Current Hypertension Reports 20:36.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L, et al. 2012. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 33:495–501.
   PubMed Web of Science ®Google Scholar
• Du M, Wang W, Huang L, Guan X, Lin W, Yao J, Li L. 2022. Natural killer cells in the pathogenesis of preeclampsia: a double-edged sword. The Journal of Maternal-Fetal & Neonatal Medicine 35:1028–1035.
   PubMed Web of Science ®Google Scholar
• Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, et al. 2011. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. Journal of Reproductive Immunology 90:105–110.
   PubMed Web of Science ®Google Scholar
• Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. 2016. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound in Obstetrics & Gynecology 48:333–339.
   PubMed Web of Science ®Google Scholar
• Gu W, Lin J, Hou Y-Y, Lin N, Song M-F, Zeng W-J, et al. 2020. Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: a randomized controlled trial from Shanghai, China. European Journal of Obstetrics & Gynecology and Reproductive Biology 248:156–163.
   PubMed Web of Science ®Google Scholar
• Herzog EM, Eggink AJ, Reijnierse A, Kerkhof MAM, de Krijger RR, Roks AJM, et al. 2017. Impact of early- and late-onset preeclampsia on features of placental and newborn vascular health. Placenta 49:72–79.
   PubMed Web of Science ®Google Scholar
• Hudić I, Stray-Pedersen B, Szekeres-Bartho J, Fatušić Z, Dizdarević-Hudić L, Tomić V, et al. 2015. Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth. Journal of Reproductive Immunology 109:36–40.
   PubMed Web of Science ®Google Scholar
• Kumar A, Begum N, Prasad S, Agarwal S, Sharma S. 2013. IL-10, TNF-α & IFN-γ: Potential early biomarkers for preeclampsia. Cellular Immunology 283:70–74.
   PubMed Web of Science ®Google Scholar
• McLaughlin K, Baczyk D, Potts A, Hladunewich M, Parker JD, Kingdom JC. 2017. Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia. Hypertension 69:180–188.
   PubMed Web of Science ®Google Scholar
• Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE. 2014. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. The Journal of Maternal-Fetal & Neonatal Medicine 27:1038–1048.
   PubMed Web of Science ®Google Scholar
• Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Fierro IM. 2007. Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism. Thrombosis and Haemostasis 97:88–98.
   PubMed Web of Science ®Google Scholar
• No authors 2018. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstetrics & Gynecology 132:e44–e52.
   PubMedGoogle Scholar
• No authors 2019. Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 202. American College of Obstetricians and Gynecologists. Obstetrics & Gynecology 133:e1–e25.
   Web of Science ®Google Scholar
• No authors 2020. Gestational hypertension and preeclampsia: ACOG practice bulletin, Number 222. Obstetrics & Gynecology 135: e237–e260.
   PubMed Web of Science ®Google Scholar
• Ozkan ZS, Simsek M, Ilhan F, Deveci D, Godekmerdan A, Sapmaz E. 2014. Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease. The Journal of Maternal-Fetal & Neonatal Medicine 27:1513–1517.
   PubMed Web of Science ®Google Scholar
• Parkinson JF. 2006. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflammation & Allergy Drug Targets 5:91–106.
   PubMedGoogle Scholar
• Pihl K, Sørensen S, Jørgensen FS. 2020. Prediction of preeclampsia in nulliparous women according to first trimester maternal factors and serum markers. Fetal Diagnosis and Therapy 47:277–283.
   PubMed Web of Science ®Google Scholar
• Polgár B, Nagy E, Mikó É, Varga P, Szekeres-Barthó J. 2004. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biology of Reproduction 71:1699–1705.
   PubMed Web of Science ®Google Scholar
• Rein DT, Schöndorf T, Göhring U-J, Kurbacher CM, Pinto I, Breidenbach M, et al. 2002. Cytokine expression in peripheral blood lymphocytes indicates a switch to Thelper cells in patients with preeclampsia. Journal of Reproductive Immunology 54:133–142.
   PubMed Web of Science ®Google Scholar
• Roberge S, Bujold E, Nicolaides KH. 2018. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 218:287–293.e1.
   PubMed Web of Science ®Google Scholar
• Romero R, Romero R. (2009). Prenatal medicine: the child is the father of the man. The Journal of Maternal-Fetal & Neonatal Medicine 22:636–639.
   Google Scholar
• Sahin E, Madendag Y, Tayyar AT, Sahin ME, Col Madendag I, Acmaz G, et al. 2018. Perinatal outcomes in uncomplicated late preterm pregnancies with borderline oligohydramnios. The Journal of Maternal-Fetal & Neonatal Medicine 31:3085–3088.
   PubMed Web of Science ®Google Scholar
• Salazar Garcia MD, Mobley Y, Henson J, Davies M, Skariah A, Dambaeva S, et al. 2018. Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia. Journal of Reproductive Immunology 125:25–31.
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Alfirevic Z, Da Silva Costa F, Deter RL, Figueras F, Ghi T, et al. 2019. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound in Obstetrics & Gynecology 53:715–723.
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Rozenberg P, Szekeres-Bartho J, Malagrida L, Giudicelli Y, Ville Y. 2005. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks. The Journal of Maternal-Fetal & Neonatal Medicine 17:353–356.
   PubMed Web of Science ®Google Scholar
• Silasi M, Cohen B, Karumanchi SA, Rana S. 2010. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstetrics and Gynecology Clinics of North America 37:239–253.
   PubMed Web of Science ®Google Scholar
• Sobel ML, Kingdom J, Drewlo S. 2011. Angiogenic response of placental villi to heparin. Obstetrics & Gynecology 117:1375–1383.
   PubMed Web of Science ®Google Scholar
• Szekeres-Bartho J, Kilaŕ F, Falkay G, Csernus V, Török A, Pacsa AS. 1985. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. American Journal of Reproductive Immunology and Microbiology 9:15–18.
   PubMed Web of Science ®Google Scholar
• Szekeres-Bartho J, Schindler AE. 2019. Progestogens and immunology. Best Practice & Research. Clinical Obstetrics & Gynaecology 60:17–23.
   PubMed Web of Science ®Google Scholar
• Szekeres-Bartho J, Faust Z, Varga P, Szereday L, Kelemen K. 1996. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. American Journal of Reproductive Immunology 35:348–351.
   PubMed Web of Science ®Google Scholar
• Xu J, Gu Y, Sun J, Zhu H, Lewis DF, Wang Y. 2018. Reduced CD 200 expression is associated with altered Th1/Th2 cytokine production in placental trophoblasts from preeclampsia. American Journal of Reproductive Immunology 79:e12763.
   Web of Science ®Google Scholar
• Yang X, Yang Y, Yuan Y, Liu L, Meng T. 2020. The roles of uterine natural killer (NK) cells and KIR/HLA-C combination in the development of preeclampsia: a systematic review. BioMed Research International 2020:4808072.
   PubMed Web of Science ®Google Scholar
• Yang Y, Su X, Xu W, Zhou R. 2014. Interleukin-18 and interferon gamma levels in preeclampsia: a systematic review and meta-analysis. American Journal of Reproductive Immunology 72:504–514.
   PubMed Web of Science ®Google Scholar
• Zhang J, Tian Z. 2007. UNK cells: their role in tissue re-modelling and preeclampsia. Seminars in Immunopathology 29:123–133.
   PubMed Web of Science ®Google Scholar